tradingkey.logo
搜尋

Amneal Pharmaceuticals Inc

AMRX
添加自選
17.310USD
+0.020+0.12%
收盤 06/30, 16:00美東報價延遲15分鐘
5.52B總市值
44.64本益比TTM

關於 Amneal Pharmaceuticals Inc 公司

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Inc簡介

公司代碼AMRX
公司名稱Amneal Pharmaceuticals Inc
上市日期Nov 18, 2009
CEOPatel (Chintu)
員工數量8100
證券類型Ordinary Share
年結日Nov 18
公司地址400 Crossing Boulevard, 3rd Floor
城市BRIDGEWATER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編08807
電話19089473120
網址https://amneal.com/
公司代碼AMRX
上市日期Nov 18, 2009
CEOPatel (Chintu)

Amneal Pharmaceuticals Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

常見問題

Amneal Pharmaceuticals Inc的前五大股東是誰?

Amneal Pharmaceuticals Inc的前五大股東如下:Mr. Chintu Patel

有多少機構持有Amneal Pharmaceuticals Inc(AMRX)的股份?

截至2026Q1,共有521家機構持有Amneal Pharmaceuticals Inc的股份,合計持有的股份價值約為161.64M,占公司總股份的50.67% 。與2025Q4相比,機構持股有所增加,增幅為-25718515.00。

哪個業務部門對Amneal Pharmaceuticals Inc的收入貢獻最大?

在2026Q1,Oral solid業務部門對Amneal Pharmaceuticals Inc的收入貢獻最大,創收726.38M,占總收入的24.06% 。
KeyAI